|ITEM METADATA RECORD
|Title: ||The crystal study: Assessment of the predictive value of KRAS status on clinical outcome in patients with mcrc receiving first-line treatment with cetuximab or cetuximab plus folfiri|
|Authors: ||Van Cutsem, Eric|
Rougier, P #
|Issue Date: ||2008 |
|Publisher: ||Kluwer Academic Publishers|
|Host Document: ||Annals of Oncology vol:19 pages:17-18|
|Conference: ||World Congress on Gastrointestinal Cancer edition:10 location:Barcelona, Spain date:25 June - 28 June, 2008|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Molecular Digestive Oncology (+)|
Clinical Digestive Oncology (+)
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.